Stockscreener 앱 받기
0.6753
0.97%
-0.0066
시장 영업 전:
.68
0.0047
+0.70%
Nexgel Inc 주식(NXGL)의 최신 뉴스
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com
NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Oxford Industries Earnings: What To Look For From OXM - Barchart
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo
Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn
Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo
NexGel (NXGL) Expected to Announce Earnings on Monday - Defense World
NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria
UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com
NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks
NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView
Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan
Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView
NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative
NEXGEL Signs Definitive Agreement to License and Acquire - GlobeNewswire
EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue - Benzinga
2 Reasons to Like CALM (and 1 Not So Much) - Barchart.com
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
NEXGEL CEO Adam Levy to Join 6th Annual Semco Capital Networking Event in Chicago - MSN
Is NEXGEL Inc. Equity Warrant stock resilient to inflationWeekly Trade Summary & Weekly High Return Opportunities - Naître et grandir
NEXGEL Expands Partnership With STADA, Secures $1 Million to Fuel New Product Launches - MSN
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.04 - Markets Mojo
Stocks in play: Quarterhill Inc. - Barchart
Head to Head Survey: Pacific Biosciences of California (NASDAQ:PACB) and NexGel (NASDAQ:NXGL) - Defense World
NexGel, Inc. Hits New 52-Week Low at $1.05 Amidst Decline - Markets Mojo
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.09 - Markets Mojo
NXGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NXGL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NexGel, Inc. Hits New 52-Week Low at USD 1.15 Amid Decline - Markets Mojo
NexGel, Inc. Hits New 52-Week Low at $1.11 Amidst Declining Performance - Markets Mojo
NXGLW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Earnings Report: Is NEXGEL Inc currently under institutional pressureRate Cut & Weekly Watchlist of Top Performers - baoquankhu1.vn
Big Picture: Is NEXGEL Inc stock a good pick for beginnersJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Hedge Fund Bets: Will NEXGEL Inc outperform the market in YEARWeekly Earnings Recap & Reliable Price Breakout Alerts - baoquankhu1.vn
Gains Report: Is NEXGEL Inc stock a hidden gemM&A Rumor & High Win Rate Trade Alerts - baoquankhu1.vn
What is the cash position of NEXGEL Inc.July 2025 Market Mood & Fast Entry and Exit Trade Plans - mfd.ru
Fed Meeting: What is the earnings history of NEXGEL Inc. Equity WarrantBond Market & Weekly High Return Forecasts - mfd.ru
Will NEXGEL Inc. Equity Warrant stock gain from lower inflation2025 Geopolitical Influence & AI Driven Price Forecasts - mfd.ru
Market Outlook: How does NEXGEL Inc Equity Warrant compare to its peers2025 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Aug Setups: How supply chain issues affect NEXGEL Inc. stock2025 Historical Comparison & Consistent Profit Trading Strategies - mfd.ru
NEXGEL Secures $1.8 Million Financing for Potential Acquisition - MyChesCo
Is NEXGEL Inc. Equity Warrant still a buy after recent gainsAnalyst Upgrade & Risk Controlled Stock Pick Alerts - mfd.ru
Why NEXGEL Inc. stock could be next big winnerForecast Cut & Low Risk High Reward Ideas - mfd.ru
0.95%
0.04%
자본화:
|
볼륨(24시간):